These Healthcare Stocks Have Very Low P/E Ratios in the Sector

The following five companies in the Healthcare sector have low trailing price-to-earnings ratios (excludes all companies with a market capitalization less than $500 million):

  1. Eli Lilly & Co. (NYSE:LLY):  The stock has traded in a 52-week range of $32.02 to $38.75 and most recently traded at a price of $38.68 per share.  Its trailing price-to-earnings ratio is 8.80, its trailing price-to-sales ratio is 1.83, and its trailing price-to-book ratio is 3.08.  Its market capitalization is $43.03 billion.  About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals.  The Company’s products are sold in countries around the world.  Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  2. AstraZeneca plc (NYSE:AZN):  The stock has traded in a 52-week range of $40.41 to $53.53 and most recently traded at $51.43 per share.  Its trailing price-to-earnings ratio is 9, its trailing price-to-sales ratio is 2.14, and its trailing price-to-book ratio is 3.15.  Its market capitalization is $71.21 billion.  About the company: About the company: AstraZeneca PLC is a holding company.  Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products.  The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
  3. PDL BioPharma, Inc. (NASDAQ:PDLI):  The stock has traded in a 52-week range of $4.66 to $6.75 and most recently traded at $6.26 per share.  Its trailing price-to-earnings ratio is 9.74, its trailing price-to-sales ratio is 2.49, and its trailing price-t0-book value ratio is N/A (book value per share is $0.00).  Its market capitalization is $874 million.  About the company:  PDL BioPharma Inc. discovers, develops, and markets therapies for serious or life-threatening illnesses, commercially focused on the acute care, hospital setting.
  4. Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA):  The stock has traded in a 52-week range of $44.86 to $59.74 and most recently traded at $47.20 per share.  Its trailing price-to-earnings ratio is 12.88, its trailing price-to-sales ratio is 2.62, and its trailing price-to-book ratio is 1.93.  Its market capitalization is $42.4 billion.  About the company:  Teva Pharmaceutical Industries, Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients.  The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.  Teva develops novel drugs for diseases of the central nervous system.
  5. The Ensign Group, Inc. (NASDAQ:ENSG):  Its stock has traded in a 52-week range of $15.01 to $34.85 and most recently traded at $28.15 per share.  Its trailing price-to-earnings ratio is 13.59, its trailing price-to-sales ratio is 0.85, and its trailing price-to-book ratio is 2.37.  Its market capitalization is $588 million.  About the company:  Ensign Group, Inc. operates facilities offering nursing and rehabilitative care services in multiple states.  The Company provides a broad spectrum of nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients.

Note: Financial data is taken from Yahoo! Finance.  Selected other data is taken from Google Finance and publicly available SEC filings.  All data are assumed to be accurate.

Fresh Off the Press: Wall St. Cheat Sheet’s newest Feature Trades of the Month!